Groundbreaking Genomic Test Could Spare Millions from Chemotherapy
A groundbreaking genomic test could spare millions of breast cancer patients chemotherapy, according to trial results that may transform global healthcare guidelines. The findings will be presented at the American Society of Clinical Oncology’s annual meeting in Chicago.